Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 9, 2010, Pages 1031-1037

  Massare, Jorge ^a   Berry, Jeff M ^a   Luo, Xiang ^a   Rob, Farhana ^a   Johnstone, Janet L ^a   Shelton, John M ^a   Bassel Duby, Rhonda ^b   Hill, Joseph A ^a,b   Naseem, R Haris ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

dilated cardiomyopathy; fibrosis; histone deacetylases; protein kinase D; ventricular tachycardia

Indexed keywords

COLLAGEN; HISTONE DEACETYLASE 2; MUTANT PROTEIN; PROTEIN KINASE; PROTEIN KINASE D1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME INHIBITION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE OVEREXPRESSION; HEART MASSAGE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PACING; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HISTOLOGY; INTERSTITIUM; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SYSTOLIC DYSFUNCTION; THORACIC AORTA; TRANSGENIC MOUSE;

ACTION POTENTIALS; ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FIBROSIS; GENOTYPE; HEART FAILURE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; MYOCARDIUM; PHENOTYPE; PROTEIN KINASE C; TACHYCARDIA, VENTRICULAR; UP-REGULATION; VENTRICULAR REMODELING;

EID: 77956319635     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01736.x     Document Type: Article

References (39)

1. Hill JA, Olson EN : Cardiac plasticity. N Engl J Med 2008 358 : 1370 80.
2. Frey N, Olson EN : Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol 2003 65 : 45 79.
3. Nass RD, Aiba T, Tomaselli GF, Akar FG : Mechanisms of disease: Ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovas Med 2008 5 : 196 207.
4. Spinale FG : Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007 87 : 1285 342.
5. Tomaselli GF, Zipes DP : What causes sudden death in heart failure? Circ Res 2004 95 : 754 763.
6. Manabe I, Shindo T, Nagai R : Gene expression in fibroblasts and fibrosis: Involvement in cardiac hypertrophy. Circ Res 2002 91 : 1103 1113.
7. Weber KT : Fibrosis in hypertensive heart disease: Focus on cardiac fibroblasts. J Hypertens 2004 22 : 47 50.
8. Backs J, Olson EN : Control of cardiac growth by histone acetylation/deacetylation. Circ Res 2006 98 : 15 24.
9. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, Hill JA : Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 2006 113 : 2579 2588.
10. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN, McKinsey TA : Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004 24 : 8374 8385.
11. Fielitz J, Kim MS, Shelton JM, Qi X, Hill JA, Richardson JA, Bassel-Duby R, Olson EN : Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci USA 2008 105 : 3059 3063.
12. Harrison BC, Kim MS, van Rooij E, Plato CF, Papst PJ, Vega RB, McAnally JA, Richardson JA, Bassel-Duby R, Olson EN, McKinsey TA : Regulation of cardiac stress signaling by protein kinase d1. Mol Cell Biol 2006 26 : 3875 3888.
13. Zeppenfeld K, Stevenson WG : Ablation of ventricular tachycardia in patients with structural heart disease. Pacing Clin Electrophysiol 2008 31 : 358 374.
14. Spach MS, Boineau JP : Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: A major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 1997 20 : 397 413.
15. Miragoli M, Gaudesius G, Rohr S : Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 2006 98 : 801 810.
16. Miragoli M, Salvarani N, Rohr S : Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 2007 101 : 755 758.
17. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R : Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007 13 : 952 961.
18. Brilla CG, Matsubara LS, Weber KT : Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993 25 : 563 575.
19. Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ : Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int 2009 Epub Feb : 1523 1755.
20. Van Den Borne SW, Isobe S, Zandbergen HR, Li P, Petrov A, Wong ND, Fujimoto S, Fujimoto A, Lovhaug D, Smits JF, Daemen MJ, Blankesteijn WM, Reutelinsgsperger C, Zannad F, Narula N, Vannan MA, Pitt B, Hofstra L, Narula J : Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging 2009 2 : 187 198.
21. Everett THt, Olgin JE : Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007 4 (3 Suppl S24 S27.
22. Rothermel BA, Berenji K, Tannous P, Kutschke W, Dey A, Nolan B, Yoo KD, Demetroulis E, Gimbel M, Cabuay B, Karimi M, Hill JA : Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics 2005 23 : 18 27.
23. Woods AE, Ellis RC : Laboratory Histopathology, A Complete Reference. Churchill : Livingston Press 1996.
24. Woessner JF Jr. : The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961 93 : 440 447.
25. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, Wang Z, Kerber RE, Weiss RM : Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 2000 101 : 2863 2869.
26. Hill JA, Rothermel B, Yoo KD, Cabuay B, Demetroulis E, Weiss RM, Kutschke W, Bassel-Duby R, Williams RS : Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. J Biol Chem 2002 277 : 10251 10255.
27. Wang Y, Tandan S, Cheng J, Yang C, Nguyen L, Sugianto J, Johnstone JL, Sun Y, Hill JA : Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. J Biol Chem 2008 283 : 25524 25532.
28. Berul CI, Christe ME, Aronovitz MJ, Maguire CT, Seidman CE, Seidman JG, Mendelsohn ME : Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J Interv Card Electrophysiol 1998 2 : 7 14.
29. Maguire CT, Wakimoto H, Patel VV, Hammer PE, Gauvreau K, Berul CI : Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies. Physiol Genomics 2003 15 : 84 91.
30. Petrov VV, Fagard RH, Lijnen PJ : Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002 39 : 258 263.
31. Laflamme MA, Murry CE : Regenerating the heart. Nat Biotechnol 2005 23 : 845 856.
32. Duffy HS : Cardiac connections-the antiarrhythmic solution? N Engl J Med 2008 358 : 1397 1398.
33. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, Breitbach M, Doran R, Becher UM, Hwang SM, Bostani T, von Maltzahn J, Hofmann A, Reining S, Eiberger B, Gabris B, Pfeifer A, Welz A, Willecke K, Salama G, Schrickel JW, Kotlikoff MI, Fleischmann BK : Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007 450 : 819 824.
34. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ : Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001 88 : 275 279.
35. Brown RD, Ambler SK, Mitchell MD, Long CS : The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Ann Rev Pharmacol Toxicol 2005 45 : 657 687.
36. Maturana AD, Walchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S : Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel. Cardiovasc Res 2008 78 : 458 465.
37. Ten Tusscher KH, Panfilov AV : Influence of diffuse fibrosis on wave propagation in human ventricular tissue. Europace 2007 9 (Suppl 6 vi38 vi45.
38. Darbar D, Roden DM : Future of antiarrhythmic drugs. Curr Opin Cardiol 2006 21 : 361 367.
39. Berry JM, Cao DJ, Rothermel BA, Hill JA : Histone deacetylase inhibition in the treatment of heart disease. Expert Opin Drug Saf 2008 7 : 53 67.